UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improving resource utilization: Axillary lymph node core biopsy triaging for lymphoma

American journal of clinical pathology, 2024-09, Vol.162 (3), p.227-232

2024

Volltextzugriff (PDF)

A Unicorn in a Field of Horses: In Situ Papillary Breast CarcinomaWith Lobular Differentiation

Archives of pathology & laboratory medicine (1976), 2024-09, Vol.148 (9), p.E254-E255

2024

Volltextzugriff (PDF)

Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer

Journal of personalized medicine, 2024-05, Vol.14 (5), p.478

2024

Volltextzugriff (PDF)

Selective breast/gynecologic pathology fellowship training in the United States: Experience of program directors

Academic pathology, 2024-01, Vol.11 (1), p.100103-100103, Article 100103

2024

Volltextzugriff (PDF)

Axillary node evaluation and biopsy: Predictors of malignancy based on sonographic morphology and mode of detection

Clinical imaging, 2023-12, Vol.104, p.110014, Article 110014

2023

Volltextzugriff (PDF)

Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy

Breast cancer research and treatment, 2023-10, Vol.201 (3), p.387-396

2023

Volltextzugriff (PDF)

Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)‐like change: clinicopathological and molecular characteristics

Histopathology, 2023-09, Vol.83 (3), p.357-365

2023

Volltextzugriff (PDF)

Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer

Frontiers in oncology, 2023-06, Vol.13, p.1179025-1179025

2023

Volltextzugriff (PDF)

Abstract OT2-01-02: The SMILE Study: A phase II trial of onapristone in combination with fulvestrant for patients with ER-positive and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK 4/6 inhibitors

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.OT2-01-02-OT2-01-02

2023

Volltextzugriff (PDF)

Abstract P2-11-13: High PD-L2 Protein Expression in Cancer Cells is an Independent Marker of Unfavorable Prognosis in Luminal Breast Tumors

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P2-P2-11-13

2023

Volltextzugriff (PDF)

Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens

The American journal of surgery, 2023-02, Vol.225 (2), p.304-308

2023

Volltextzugriff (PDF)

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

Modern pathology, 2023-01, Vol.36 (1), p.100032-100032, Article 100032

2023

Volltextzugriff (PDF)

High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer

JCO precision oncology, 2023-01, Vol.7 (7), p.e2100498

2023

Volltextzugriff (PDF)

Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma

Breast cancer research and treatment, 2022-12, Vol.196 (3), p.453-461

2022

Volltextzugriff (PDF)

Assessment of Quality of Frozen Section Services at a Large Academic Hospital Before and After Relocation

American journal of clinical pathology, 2022-11, Vol.158 (5), p.655-663

2022

Volltextzugriff (PDF)

Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database

Annals of surgical oncology, 2022-10, Vol.29 (10), p.6339-6346

2022

Volltextzugriff (PDF)

ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology

Annals of surgical oncology, 2022-10, Vol.29 (10), p.6347-6348

2022

Volltextzugriff (PDF)

New Challenges in the Differential Diagnosis of High-Grade Triple-Negative Breast Cancer and Serous Carcinoma

International journal of surgical pathology, 2022-10, Vol.30 (7), p.728-733

2022

Volltextzugriff (PDF)

ASO Visual Abstract: Primary Breast Neuroendocrine Tumors—An Analysis of the National Cancer Database

Annals of surgical oncology, 2022-10, Vol.29 (10), p.6349-6349

2022

Volltextzugriff (PDF)

Patient Use of Pathology Reports via Online Portals: What Have We Learned and Where Are We Going?

Archives of pathology & laboratory medicine (1976), 2022-09, Vol.146 (9), p.1053-1055

2022

Volltextzugriff (PDF)

Patient Use of Pathology Reports via Online Portals

Archives of pathology & laboratory medicine (1976), 2022-09, Vol.146 (9), p.1053-1055

2022

Volltextzugriff (PDF)

Subcategorization of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens for Predicting Progression

Archives of pathology & laboratory medicine (1976), 2022-09, Vol.146 (9), p.1131-1139

2022

Volltextzugriff (PDF)

Automated assessment of breast margins in deep ultraviolet fluorescence images using texture analysis

Biomedical optics express, 2022-09, Vol.13 (9), p.5015-5034

2022

Volltextzugriff (PDF)

Abstracts and Case Studies From the College of American Pathologists 2022 Annual Meeting (CAP22)

Archives of pathology & laboratory medicine (1976), 2022-09, Vol.146 (9), p.e2-e186

2022

Volltextzugriff (PDF)

What's new in breast pathology 2022: WHO 5th edition and biomarker updates

Journal of Pathology and Translational Medicine, 2022, 56(3), , pp.170-171

2022

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(106)

Sprache

Englisch
(106)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improving resource utilization: Axillary lymph node core biopsy triaging for lymphoma

A Unicorn in a Field of Horses: In Situ Papillary Breast CarcinomaWith Lobular Differentiation

Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer

Selective breast/gynecologic pathology fellowship training in the United States: Experience of program directors

Axillary node evaluation and biopsy: Predictors of malignancy based on sonographic morphology and mode of detection

Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy

Giant juvenile fibroadenomas with and without prominent pseudoangiomatous stromal hyperplasia (PASH)‐like change: clinicopathological and molecular characteristics

Deep learning classification of deep ultraviolet fluorescence images toward intra-operative margin assessment in breast cancer

Abstract OT2-01-02: The SMILE Study: A phase II trial of onapristone in combination with fulvestrant for patients with ER-positive and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK 4/6 inhibitors

Abstract P2-11-13: High PD-L2 Protein Expression in Cancer Cells is an Independent Marker of Unfavorable Prognosis in Luminal Breast Tumors

Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens

Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry

High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer

Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma

Assessment of Quality of Frozen Section Services at a Large Academic Hospital Before and After Relocation

Primary Breast Neuroendocrine Tumors: An Analysis of the National Cancer Database

ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology

New Challenges in the Differential Diagnosis of High-Grade Triple-Negative Breast Cancer and Serous Carcinoma

ASO Visual Abstract: Primary Breast Neuroendocrine Tumors—An Analysis of the National Cancer Database

Patient Use of Pathology Reports via Online Portals: What Have We Learned and Where Are We Going?

Patient Use of Pathology Reports via Online Portals

Subcategorization of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens for Predicting Progression

Automated assessment of breast margins in deep ultraviolet fluorescence images using texture analysis

Abstracts and Case Studies From the College of American Pathologists 2022 Annual Meeting (CAP22)

What's new in breast pathology 2022: WHO 5th edition and biomarker updates

Suchergebnisse filtern